Literature DB >> 16267005

High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer.

Michael Bouvet1, Joseph Spernyak, Matthew H Katz, Richard V Mazurchuk, Shinako Takimoto, Ralph Bernacki, Youcef M Rustum, Abdool R Moossa, Robert M Hoffman.   

Abstract

We have developed genetically fluorescent orthotopic models of human pancreatic cancer. In these models, noninvasive fluorescent protein imaging (FPI) of internal primary tumors and metastatic deposits has been carried out. Whole-body tumor images are easily and inexpensively obtained using FPI, permitting both detection and quantification of tumor load. In this study, we simultaneously compared single mice with a highly fluorescent, red fluorescent protein-expressing orthotopic pancreatic cancer xenografts with both FPI and high-resolution magnetic resonance imaging (MRI). Images were acquired at multiple time points after tumor implantation in the pancreas. Indwelling pancreatic primary tumors and metastatic foci were detected by both FPI and MRI. Moreover, a strong correlation existed between images taken with these two technologies. FPI permitted rapid, high-throughput imaging without the need for either anesthesia or contrast agents. Both FPI and MRI enabled accurate imaging of tumor growth and metastasis, although MRI enabled tissue structure to be visualized as well. FPI has high resolution and is exceedingly rapid with instant image capture. We suggest a complimentary role for these two imaging modalities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267005     DOI: 10.1158/0008-5472.CAN-05-1548

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Far-red fluorescent cell line for preclinical study of HER2-targeted agents.

Authors:  I V Balalaeva; E A Sokolova; A A Brilkina; S M Deyev; R V Petrov
Journal:  Dokl Biochem Biophys       Date:  2016-01-05       Impact factor: 0.788

2.  Divalent cations modulate alpha2beta1 integrin-mediated malignancy in a novel 3-dimensional in vitro model of pancreatic cancer.

Authors:  John J Grzesiak; Fabian Vargas; Michael Bouvet
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

3.  Enhancing magnetic resonance imaging tumor detection with fluorescence intensity and lifetime imaging.

Authors:  Ahmet Erten; David Hall; Carl Hoh; Hop S Tran Cao; Sharmeela Kaushal; Sadik Esener; Robert M Hoffman; Michael Bouvet; James Chen; Santosh Kesari; Milan Makale
Journal:  J Biomed Opt       Date:  2010 Nov-Dec       Impact factor: 3.170

4.  Magnetic resonance and fluorescence-protein imaging of the anti-angiogenic and anti-tumor efficacy of selenium in an orthotopic model of human colon cancer.

Authors:  Arup Bhattacharya; Steve G Turowski; Ivan Dominguez San Martin; Ashwani Rajput; Youcef M Rustum; Robert M Hoffman; Mukund Seshadri
Journal:  Anticancer Res       Date:  2011-02       Impact factor: 2.480

5.  Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer.

Authors:  Paul T Winnard; Jessica B Kluth; Venu Raman
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

6.  Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer.

Authors:  Hop S Tran Cao; Sharmeela Kaushal; Cynthia S Snyder; Weg M Ongkeko; Robert M Hoffman; Michael Bouvet
Journal:  Anticancer Res       Date:  2010-11       Impact factor: 2.480

7.  N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, and tissue architecture disruption.

Authors:  Therese B Deramaudt; Munenori Takaoka; Rabi Upadhyay; Mark J Bowser; Jess Porter; Amy Lee; Ben Rhoades; Cameron N Johnstone; Ralph Weissleder; Sunil R Hingorani; Umar Mahmood; Anil K Rustgi
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

8.  Morphologic changes of mammary carcinomas in mice over time as monitored by flat-panel detector volume computed tomography.

Authors:  Jeannine Missbach-Guentner; Christian Dullin; Sarah Kimmina; Marta Zientkowska; Melanie Domeyer-Missbach; Cordula Malz; Eckhardt Grabbe; Walter Stühmer; Frauke Alves
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

Review 9.  Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.

Authors:  Thinzar M Lwin; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Oncol       Date:  2018-08-06       Impact factor: 3.454

Review 10.  Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis.

Authors:  Wanglong Qiu; Gloria H Su
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.